- Home
- AUPH vs ACEL Comparison
AUPH vs ACEL Comparison
Compare AUPH & ACEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUPH
- ACEL
- Stock Information
- Founded
- AUPH 1993
- ACEL 2009
- Country
- AUPH Canada
- ACEL United States
- Employees
- AUPH N/A
- ACEL N/A
- Industry
- AUPH Biotechnology: Pharmaceutical Preparations
- ACEL Services-Misc. Amusement & Recreation
- Sector
- AUPH Health Care
- ACEL Consumer Discretionary
- Exchange
- AUPH Nasdaq
- ACEL Nasdaq
- Market Cap
- AUPH 999.8M
- ACEL 818.8M
- IPO Year
- AUPH 1999
- ACEL N/A
- Fundamental
- Price
- AUPH $7.85
- ACEL $11.73
- Analyst Decision
- AUPH Strong Buy
- ACEL Strong Buy
- Analyst Count
- AUPH 2
- ACEL 2
- Target Price
- AUPH $11.50
- ACEL $16.00
- AVG Volume (30 Days)
- AUPH 1.1M
- ACEL 440.6K
- Earning Date
- AUPH 05-12-2025
- ACEL 05-05-2025
- Dividend Yield
- AUPH N/A
- ACEL N/A
- EPS Growth
- AUPH N/A
- ACEL N/A
- EPS
- AUPH 0.27
- ACEL 0.49
- Revenue
- AUPH $247,295,000.00
- ACEL $1,253,067,000.00
- Revenue This Year
- AUPH $11.86
- ACEL $8.78
- Revenue Next Year
- AUPH $24.96
- ACEL $4.41
- P/E Ratio
- AUPH $29.71
- ACEL $24.08
- Revenue Growth
- AUPH 29.20
- ACEL 6.28
- 52 Week Low
- AUPH $4.98
- ACEL $9.02
- 52 Week High
- AUPH $10.67
- ACEL $12.96
- Technical
- Relative Strength Index (RSI)
- AUPH 44.68
- ACEL 63.11
- Support Level
- AUPH $7.89
- ACEL $11.29
- Resistance Level
- AUPH $8.49
- ACEL $11.91
- Average True Range (ATR)
- AUPH 0.30
- ACEL 0.31
- MACD
- AUPH -0.02
- ACEL 0.07
- Stochastic Oscillator
- AUPH 36.95
- ACEL 89.71
About AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About ACEL Accel Entertainment Inc.
Accel Entertainment Inc is a distributed gaming and local entertainment operator in the United States. It is engaged in the installation, maintenance, operation, and servicing of gaming terminals and related equipment, redemption devices that disburse winnings and contain automated teller machine (ATM) functionality, and amusement devices in authorized non-casino locations such as restaurants, bars, taverns, convenience stores, liquor stores, truck stops, and grocery stores. The Company also operates stand-alone ATMs in gaming and non-gaming locations. It generates revenue from Net gaming, Amusement, Manufacturing, ATM fees, and others.